文献速递贫血与红细胞疾病

隐性营养不良型大疱性表皮松解症相关慢性贫血中铁代谢、炎症与EPO-ERFE-铁调素轴的相互作用

Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia.
PubMed 文献 · Blood Adv · 2025-01-01

这项横断面研究分析按疾病严重度、贫血和铁状态分层的隐性营养不良型大疱性表皮松解症(RDEB)代表性队列,发现贫血占50%,血红蛋白与受累体表面积百分比及C反应蛋白(CRP)强负相关,90%贫血患者网织红细胞生成指数提示骨髓反应不足。

要点

  • RDEB队列中贫血占50%,血红蛋白与受累体表面积百分比及CRP呈强负相关。
  • 所有贫血患者均见中重度炎症(CRP ≥ 15 mg/L),但无特定细胞因子谱与贫血风险相关。
  • 90%贫血患者网织红细胞生成指数提示骨髓反应不足,与促红细胞生成素水平无关。

核心结论

  • RDEB慢性贫血与炎症及铁调节异常复杂交织,EPO-ERFE-铁调素轴调节与按贫血严重度和铁状态预期的模式存在差异。
  • 作者认为需要个体化、针对性的方法来改善RDEB及其他慢性炎症性疾病的贫血管理。

研究设计与样本

  • 横断面研究,分析一个按疾病严重度、贫血和铁状态分层的RDEB代表性队列,检测血液学参数、细胞因子谱及EPO-ERFE-铁调素轴。

主要发现

  • 贫血存在于50%的队列中。
  • 血红蛋白水平与受累体表面积百分比及CRP水平呈强负相关,二者为RDEB贫血风险因素。
  • 所有贫血患者均观察到中重度炎症(CRP ≥ 15 mg/L),但因IL-6、IL-1β、IL-10、肿瘤坏死因子和干扰素-γ水平存在变异性,无特定细胞因子谱与贫血风险相关。
  • 按网织红细胞生成指数,90%贫血患者存在骨髓反应不足,与EPO水平无关。
  • 功能性或真性铁缺乏患者ERFE水平较高,但ERFE与EPO无一致相关性,且在贫血和非贫血患者中均升高;铁调素升高主要与最高铁蛋白水平相关,多见于有铁剂输注和/或输血史的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recessive dystrophic epidermolysis bullosa (RDEB) is a genodermatosis characterized by severe cutaneous and mucosal fragility, and frequently complicated by multifactorial chronic anemia that responds poorly to conventional therapies. This cross-sectional study investigates the factors contributing to anemia in RDEB by analyzing a representative cohort, that was stratified by disease severity, anemia, and iron status, to examine their hematological parameters, cytokine profile, and the erythropoietin-erythroferrone-hepcidin (EPO-ERFE-hepcidin) axis. Anemia was present in 50% of the cohort. Hemoglobin levels showed a strong negative correlation with the percentage of body surface area affected and C-reactive protein levels (CRP), identifying these as anemia risk factors in RDEB. Moderate-severe inflammation (CRP ≥ 15 mg/L) was observed in all patients with anemia, but no specific cytokine profile was linked with anemia risk because of variability in interleukin-6 (IL-6), IL-1β, IL-10, tumor necrosis factor, and interferon-γ levels. The regulation of the EPO-ERFE-hepcidin axis showed discrepancies with the patterns expected based on patients' anemia severity and iron status. According to the reticulocyte production index, an inadequate bone marrow response was observed in 90% of patients with anemia, irrespective of EPO levels. Patients with functional or true iron deficiency had higher ERFE levels, although ERFE showed no consistent correlation with EPO and was elevated in both patients with anemia and those without anemia. Elevated hepcidin was primarily linked to the highest ferritin levels, mostly in patients with a history of iron infusions and/or transfusions. These findings highlight the need for personalized, targeted approaches that address the complex interplay between inflammation and iron dysregulation, to improve anemia management in RDEB and other chronic inflammatory conditions.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Quintana-Castanedo L, Maseda R, Pérez-Conde I, et al. Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia. Blood Adv. 2025. PMID: 40036737. doi:10.1182/bloodadvances.2024015271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。